SCHEMBL22628294

SCHEMBL22628294

C=C(CCNC(=O)COc1ccc(Cl)c(Cl)c1)NC(=O)c1cccnc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 1/20 0.57
▸ USP2 O75604 1/20 0.55
▸ KMT2A Q03164 3/20 0.53
▸ POLB P06746 1/20 0.52
▸ KDM4E B2RXH2 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ CYP3A4 P08684 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ MEN1 O00255 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ AGTR1 P30556 1/20 0.43
▸ KDR P35968 1/20 0.43
▸ GRIN1 Q05586 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25799411 0.93 RXFP1 (0.56) RXFP1USP2KMT2APOLBKDM4E
SCHEMBL22627851 0.92 RXFP1 (0.55) RXFP1USP2KMT2APOLBKDM4E
SCHEMBL25808242 0.88 GRIN1 (0.47) KMT2AKDM4ECYP2C19MEN1ALDH1A1
SCHEMBL22628080 0.85 ALDH1A1 (0.47) RXFP1USP2KMT2APOLBMEN1
SCHEMBL22628187 0.85 RXFP1 (0.57) RXFP1KMT2AMEN1ALDH1A1GRIN1
SCHEMBL22956244 0.83 GRM4 (0.48) RXFP1KMT2APOLBMEN1ALDH1A1
SCHEMBL22627651 0.83 KMT2A (0.56) KMT2AKDM4ERAB9AMEN1ALDH1A1
SCHEMBL22627776 0.82 GRIN1 (0.43) RXFP1KMT2AMEN1ALDH1A1GRIN1
SCHEMBL25803379 0.82 TDP1 (0.42) RXFP1KMT2AMEN1ALDH1A1GRIN1
SCHEMBL22956342 0.82 RXFP1 (0.52) RXFP1USP2KMT2APOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452456-B1 BICYCLIC MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2023-07-05 — — EP disclosed
US-10913727-B2 Modulators of the integrated stress pathway ABBVIE INC. (US) 2021-02-09 — — US disclosed
US-20200345727-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2020-11-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10913727-B2 Modulators of the integrated stress pathway ATF4, ATF1, DDIT3 RXFP1 2368/4885USP2 1998/4885KMT2A 4320/4885
US-20200345727-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 RXFP1 2368/4885USP2 1998/4885KMT2A 4320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback